These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Molybdocene dichloride as an antitumor agent (author's transl)].
    Author: Köpf-Maier P, Leitner M, Voigtländer R, Köpf H.
    Journal: Z Naturforsch C Biosci; 1979 Dec; 34(12):1174-6. PubMed ID: 161840.
    Abstract:
    The antitumor activity of molybdocene dichloride is tested against Ehrlich ascites tumor in CF1 mice. The application of 75 of 100 mg/kg 24 h after transplantation achieves 100% tumor inhibition until day 30. Following the d0 and d1 metallocene dichlorides of titanium and vanadium, molybdocene dichloride is the first analogous d2 system revealing similar antineoplastic properties.
    [Abstract] [Full Text] [Related] [New Search]